Latest Quarter
Q1 FY2026ended 2026-03-31 · filed 2026-05-05
$182.2M
$5.1M
$8.9M
$0.11
$65.6M
$1.05B
$782.1M
$87.3M
What this quarter tells us
For Q1 FY2026 ended March 31, 2026, Avanos Medical reported revenue of $182.2 million, up 8.8% year-over-year. Net income was $5.1 million, down 22.7% from the prior year, while diluted EPS fell 21.4% to $0.11. Operating income declined 13.6% to $8.9 million. The company held $65.6 million in cash, $87.3 million in long-term debt, and $782.1 million in equity.
- •Revenue increased 8.8% YoY to $182.2 million.
- •Net income decreased 22.7% YoY to $5.1 million.
- •Diluted EPS fell 21.4% to $0.11.
- •Operating income declined 13.6% to $8.9 million.
Informational summary based on SEC XBRL figures · generated by deepseek-v4-flash. Not investment advice.